A new study co-written by a University of Illinois Urbana-Champaign expert in operations management finds that drugs approved ...

Long before memory problems appear, your brain may already be losing neurons. That is the unsettling message from new work by ...

Genetic treatments could be the key to unlocking some rare diseases. But bringing these medicines to patients involves ...

In this part 3 of our three-part interview, Stenberg explores the evolving manufacturing paradigm in the pharmaceutical ...

A Chinese pharmaceutical company has announced that a weight-loss drug it developed for cats is currently undergoing the ...

New options for testing and treating some of the most common sexually transmitted diseases are becoming available. In the ...

The pharmaceutical sector is highly regulated, as it should be, given the direct impact on lives involved with medical care.

The US government is approving the drug leucovorin to address rising rates of autism, despite limited evidence that it works.

At the start of another new year, advocates and lawmakers are again eyeing recreational and medical marijuana legalization ...

For the approximately one-in-twelve Canadians who have a rare disease, more bureaucracy is a matter of life and death ...

ScinoPharm receives US FDA approval for glatiramer acetate injection to treat multiple sclerosis: Taiwan Tuesday, January 6, 2026, 14:00 Hrs [IST] ScinoPharm Taiwan, a professiona ...

Founded in 2016, Alpha Tau is an Israeli oncology therapeutics company that focuses on research, development, and potential commercialization of the Alpha DaRT for the treatment of solid tumors. The ...